Lymphoma, Non-Hodgkin: all 2,043 studies
Page 9 of 21. Open to participants first (309), then studies with results posted, then the rest; newest registration first within each.
- Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's LymphomaCompletedNCT00268203Phase 2Results posted
- Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's LymphomaCompletedNCT00253630Phase 2Results posted
- Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic ApproachTerminatedNCT00250718Phase 2Results posted
- Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin LymphomaCompletedNCT00244855Phase 2Results posted
- Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological MalignanciesCompletedNCT00241358Phase 1/2Results posted
- Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's LymphomaCompletedNCT00238433Phase 2Results posted
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to RituximabCompletedNCT00238238Phase 2Results posted
- Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's LymphomaCompletedNCT00225212Phase 2Results posted
- Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's LymphomaCompletedNCT00201877Phase 2Results posted
- A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's LymphomaCompletedNCT00193492Phase 2Results posted
- Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's LymphomaCompletedNCT00193479Phase 2Results posted
- CPG 7909 + Local Radiotherapy in Recurrent Low-Grade LymphomasCompletedNCT00185965Phase 1/2Results posted
- Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's LymphomaCompletedNCT00185731Phase 2Results posted
- Haploid Allogeneic Transplant Using the CliniMACS SystemTerminatedNCT00185679Phase 2Results posted
- Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's LymphomasCompletedNCT00184002Phase 2Results posted
- Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaCompletedNCT00179673Phase 2Results posted
- Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNCT00179660Phase 2Results posted
- Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins LymphomaCompletedNCT00166439Phase 2Results posted
- Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)CompletedNCT00156013Phase 1/2Results posted
- Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHLCompletedNCT00151320Phase 1/2Results posted
- Study of Low-Intensity Conditioning for Allogeneic Stem Cell TransplantCompletedNCT00143845Phase 2Results posted
- A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced CancerCompletedNCT00141297Phase 1Results posted
- Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's LymphomaCompletedNCT00131937Phase 2Results posted
- Intensive Chemotherapy and Rituximab in the Treatment of Burkitt LymphomaTerminatedNCT00126191Phase 2Results posted
- Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell LymphomaCompletedNCT00121199Phase 2Results posted
- Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00119392Phase 2Results posted
- Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00118352Phase 2Results posted
- 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's LymphomaCompletedNCT00117988Phase 2Results posted
- Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's LymphomaCompletedNCT00117156Phase 2Results posted
- Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaTerminatedNCT00112723Phase 1/2Results posted
- Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNCT00112593Not applicableResults posted
- Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's LymphomaTerminatedNCT00110149Phase 2Results posted
- S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's LymphomaCompletedNCT00109928Phase 2Results posted
- Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00105001Phase 2Results posted
- Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma PatientsCompletedNCT00103610Phase 3Results posted
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)TerminatedNCT00096460Phase 2/3Results posted
- Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHLTerminatedNCT00089284Phase 1/2Results posted
- MDX-010 in Treating Patients With Recurrent or Refractory LymphomaTerminatedNCT00089076Phase 1/2Results posted
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerCompletedNCT00089011Phase 2Results posted
- Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's LymphomaTerminatedNCT00088881Phase 2Results posted
- BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNCT00088530Phase 3Results posted
- Tipifarnib in Treating Patients With Relapsed or Refractory LymphomaCompletedNCT00082888Phase 2Results posted
- Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's LymphomaCompletedNCT00081861Phase 2Results posted
- Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00078949Phase 3Results posted
- Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's LymphomaCompletedNCT00075946Phase 3Results posted
- Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic CancerCompletedNCT00075478Phase 3Results posted
- Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's LymphomaCompletedNCT00073957Phase 2Results posted
- Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00073918Phase 2Results posted
- Study Evaluating CMC-544 In B-Cell Non-Hodgkin's LymphomaCompletedNCT00073749Phase 1Results posted
- Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid MalignanciesCompletedNCT00072514Phase 2Results posted
- S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaCompletedNCT00070018Phase 2Results posted
- Randomized Double Cord Blood Transplant StudyCompletedNCT00067002Phase 2Results posted
- Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00058019Phase 2Results posted
- Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaCompletedNCT00057811Phase 2Results posted
- Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin LymphomaCompletedNCT00054639Phase 2Results posted
- 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's LymphomaCompletedNCT00052442Phase 1/2Results posted
- Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)CompletedNCT00051025Phase 2Results posted
- Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerCompletedNCT00049504Phase 2Results posted
- Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaCompletedNCT00049036Phase 2Results posted
- Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesCompletedNCT00040846Phase 2Results posted
- Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDSCompletedNCT00025662Phase 2Results posted
- Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaTerminatedNCT00014560Phase 1Results posted
- Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00012298Phase 1/2Results posted
- Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory LymphomaCompletedNCT00005803Phase 1/2Results posted
- Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic LymphomaCompletedNCT00004228Phase 3Results posted
- SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00004031Phase 3Results posted
- Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's LymphomaCompletedNCT00003499Phase 2Results posted
- Antineoplaston Therapy in Treating Patients With Non-Hodgkin's LymphomaTerminatedNCT00003498Phase 2Results posted
- Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid LeukemiaCompletedNCT00001575Phase 1/2Results posted
- Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00001337Phase 2Results posted
- A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In GreeceActive, not recruitingNCT07814170Not applicable
- Primary Bone Mature B-Cell NHL in ChildrenCompletedNCT07721194
- A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)CompletedNCT07454863Phase 1
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsActive, not recruitingNCT07259304
- Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic LeukemiaActive, not recruitingNCT07166419Phase 1
- Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood CancersActive, not recruitingNCT07162181Phase 2
- Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphomaCompletedNCT07041827
- A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or LymphomaCompletedNCT06939283Phase 1/2
- A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersTerminatedNCT06870487Phase 1
- Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B LymphomaCompletedNCT06777290
- Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell TherapyWithdrawnNCT06767956Phase 1/2
- A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)TerminatedNCT06761586Phase 1
- A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative DisordersCompletedNCT06705530Phase 1/2
- Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's LymphomaActive, not recruitingNCT06667687Phase 1
- A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL)Active, not recruitingNCT06660563Phase 1
- 64Cu-LLP2A for Imaging Hematologic MalignanciesTerminatedNCT06636175Early Phase 1
- A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin LymphomaTerminatedNCT06622226Phase 1
- A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin LymphomaTerminatedNCT06561425Phase 1/2
- A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's LymphomaActive, not recruitingNCT06470438Phase 1
- BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.Active, not recruitingNCT06424379
- Expanded Access of Imvotamab (IGM-2323) in Patients With R/R NHLNo longer availableNCT06331832
- Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)Active, not recruitingNCT06285422Phase 1
- A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin LymphomaActive, not recruitingNCT06230224Phase 3
- Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)WithdrawnNCT06210750Phase 2
- C752 for Refractory/Relapsed B Cell Non-Hodgkin LymphomaTerminatedNCT06210243Phase 1
- Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular LymphomaActive, not recruitingNCT06191744Phase 3
- Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin LymphomaCompletedNCT06190457
- Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable
- Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)CompletedNCT06170216
- CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell LymphomaActive, not recruitingNCT06149169Phase 2